Search Results

AssayQuant Technologies, Inc announced today that it is presenting at Biotech Showcase™ 2023.

AssayQuant® Technologies, Inc. introduces KinSight™ Kinome Profiling Services providing superior results including kinetic insights into selectivity and mechanisms of action for drug discovery.

Vibliome Therapeutics, LLC, and AssayQuant Technologies, Inc., announced today that they have entered into an agreement whereby AssayQuant will provide Vibliome access to their proprietary PhosphoSens® Technology for kinome-wide profiling of Vibliome’s small molecule Type II inhibitors of kinase activity, and provide services for data-rich biochemical and kinetic assessment of their inhibitors.

Silq Technologies announced its ClearTract® Foley Catheter has received an Innovative Technology contract from Vizient, Inc., the nation’s largest provider-driven healthcare performance improvement company.

Xironetic, a provider of augmented reality surgical guidance technology, is announcing the appointment of Jeff Potts to Chief Technology Officer.

Spineart, a fast-growing company specialized in spine surgery innovation, is pleased to announce the appointment of Laurent Nodé-Langlois as Chief Technology Officer.

AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.